The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

While the top- and bottom-line numbers for ABM Industries (ABM) give a sense of how the business performed in the quarter ended October 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Tvardi To Contact Him Directly To Discuss Their Options If you suffered significant losses in Tvardi stock or options and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , Dec. 17, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Tvardi Therapeutics, Inc. ("Tvardi" or the "Company") (NASDAQ: TVRD).

Warner Bros. Discovery's (WBD) board of directors has rejected the $108 billion hostile takeover bid from David Ellison's Paramount Skydance, calling the offer “illusory,” and saying that Paramount had misled shareholders about its financing.

Minto Apartment REIT (MI.UN:CA) trades at a significant discount to NAV, offering compelling value in Canadian residential real estate. MI.UN's AFFO payout ratio is just over 60%, supporting a recently increased 4% dividend yield and robust capital returns. Strategic suite renovations and share buybacks are enhancing NAV per unit and driving rental income growth above 9% on upgraded units.

NanoViricides (NYSE-A:NNVC) is gearing up to tackle multiple viral threats with Phase 2 trials for its broad-spectrum antiviral NV-378, as analysts at Alliance Global Partners kick off coverage with a Buy rating and $6 price target. The biotechnology company, which is developing innovative antiviral therapies, is advancing its lead candidate NV-378 into Phase 2 trials next year, targeting a range of viral infections including Mpox, influenza, COVID-19, and respiratory syncytial virus (RSV), according to analysts at Alliance Global Partners.

Live Oak Bancshares, Inc. continues to deliver a solid performance despite stubborn inflation and the policy easing cycle. Its prudent loan management and asset diversification ensure it can sustain its growth and stabilize its operations. Valuation is still logical as it trades below historical averages, supported by the DCF TP of $59.79.

Nvidia's stock dropped over 2% on Wednesday as investors cashed in gains after a powerful run-up. Wednesday's sell-off marks a classic bout of profit-taking in one of this year's most crowded trades.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Firefly Aerospace To Contact Him Directly To Discuss Their Options If you purchased or otherwise acquired: (a) Firefly common stock pursuant and/or traceable to the Offering Documents (defined below) issued in connection with the Company's initial public offering conducted on or about August 7, 2025 (the "IPO" or "Offering"); and/or (b) Firefly securities between August 7, 2025 and September 29, 2025, both dates inclusive (the "Class Period") and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at …

Waymo, the Alphabet-backed robotaxi startup, has been on a tear. Soon it could be worth $100 billion.

BBAI is betting big on agentic AI to lead defense automation, backed by key acquisitions and rising investor confidence.